Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:59 PM
Ignite Modification Date:
2025-12-24 @ 3:59 PM
NCT ID:
NCT05477992
Eligibility Criteria:
For Main Study:
Inclusion Criteria
* Residual, recurrent or new primary oropharyngeal, laryngeal or hypopharyngeal cancer, in a previously irradiated field.
* Listed for TORS resection
* Who would normally be indicated for concurrent ligation of branches of their external carotid artery for peri-operative haemorrhage control
Exclusion Criteria
* Patients requiring concurrent ipsilateral neck surgery alongside their TORS resection, who would be more suited to undergo surgical vessel ligation.
* Patients known to have undergone previous ligation or embolisation of the ipsilateral external carotid artery or the relevant feeding branches.
* Females who are pregnant
* Females of childbearing potential should only be included after a confirmed menstrual period and a negative highly sensitive urine or serum pregnancy test
* Females must not be breastfeeding.
For Retrospective Sub-Study
Inclusion Criteria
* Residual, recurrent or new primary oropharyngeal, laryngeal or hypopharyngeal cancer, in a previously irradiated field
* Who underwent TORS resection to manage this disease
* Who had concurrent neck surgery for surgical ligation of branches of their external carotid artery for peri-operative haemorrhage control
Exclusion Criteria
\- Patients known to have undergone previous ligation or embolisation of the ipsilateral external carotid artery or the relevant feeding branches.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05477992
Study Brief:
Protocol Section:
NCT05477992